A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma
Language English Country Great Britain, England Media electronic
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
23295015
PubMed Central
PMC3551720
DOI
10.1186/1743-422x-10-18
PII: 1743-422X-10-18
Knihovny.cz E-resources
- MeSH
- Antiviral Agents administration & dosage MeSH
- Cytomegalovirus Retinitis complications therapy MeSH
- Cytomegalovirus isolation & purification MeSH
- Foscarnet administration & dosage MeSH
- Ganciclovir administration & dosage analogs & derivatives MeSH
- Middle Aged MeSH
- Humans MeSH
- Antibodies, Monoclonal, Murine-Derived administration & dosage MeSH
- Eye Neoplasms complications therapy MeSH
- Lymphoma, Non-Hodgkin complications therapy MeSH
- Polymerase Chain Reaction MeSH
- Antineoplastic Agents administration & dosage MeSH
- Rituximab MeSH
- Valganciclovir MeSH
- Vitrectomy MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antiviral Agents MeSH
- Foscarnet MeSH
- Ganciclovir MeSH
- Antibodies, Monoclonal, Murine-Derived MeSH
- Antineoplastic Agents MeSH
- Rituximab MeSH
- Valganciclovir MeSH
PURPOSE: To present a possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma. CASE PRESENTATION: A 47-year-old woman presented with decreased visual acuity associated with white retinal lesions in both eyes. A history of pneumonia of unknown aetiology closely preceded the deterioration of vision. Five years previously the patient was diagnosed with follicular non-Hodgkin's lymphoma. She was treated with a chemotherapy regimen comprised of cyclophosphamide, adriamycin, vincristin, and prednisone with later addition of the anti-CD20 antibody rituximab. She experienced a relapse 19 months later with involvement of the retroperitoneal lymph nodes, and commenced treatment with rituximab and 90Y-ibritumomab tiuxetan. A second relapse occurred 22 months after radioimmunotherapy and was treated with a combination of fludarabine, cyclophosphamide, and mitoxantrone followed by rituximab. The patient experienced no further relapses until the current presentation (April, 2010).Pars plana vitrectomy with vitreous fluid analysis was performed in the right eye. PCR testing confirmed the presence of cytomegalovirus in the vitreous. Atypical lymphoid elements, highly suspicious of malignancy were also found on cytologic examination. Intravenous foscarnet was administered continually for three weeks, followed by oral valganciclovir given in a dose of 900 mg twice per day. In addition, the rituximab therapy continued at three monthly intervals. Nevertheless, cessation of foscarnet therapy was followed by a recurrence of retinitis on three separate occasions during a 3-month period instigating its reinduction to the treatment regime after each recurrence. CONCLUSIONS: Cytomegalovirus retinitis is an opportunistic infection found in AIDS patients as well as in bone marrow and solid organ transplant recipients being treated with systemic immunosuppressive drugs. This case presents a less common incidence of cytomegalovirus retinitis occurring in a patient with non-Hodgkin's lymphoma. We demonstrated a possible coexistence of cytomegalovirus retinitis and intraocular lymphoma in this particular patient. The final diagnosis was based on clinical manifestations together with the course of uveitis and its response to treatment alongside the results of vitreous fluid analysis. This report highlights the importance of intraocular fluid examination in cases with nonspecific clinical manifestations. Such an examination allows for the detection of simultaneously ongoing ocular diseases of differing aetiologies and enables the prompt initiation of effective treatment.
See more in PubMed
Friedman AH. The retinal lesions of the acquired immune deficiency syndrome. Trans Am Ophthalmol Soc. 1984;82:447–491. PubMed PMC
Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92:472–484. PubMed
Henderly DE, Freeman WR, Smith RE, Causey D, Rao NA. Cytomegalovirus retinitis as the initial manifestation of the acquired immune deficiency syndrome. Am J Ophthalmol. 1987;103:316–320. PubMed
Bradfield YS, Kushner BJ, Gangnon RE. Ocular complications after organ and bone marrow transplantation in children. J AAPOS. 2005;9:426–432. doi: 10.1016/j.jaapos.2005.06.002. PubMed DOI
Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008;10:13–18. doi: 10.1111/j.1399-3062.2007.00241.x. PubMed DOI
Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007;4:e334. doi: 10.1371/journal.pmed.0040334. PubMed DOI PMC
Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D. Studies of Ocular Complications of AIDS (SOCA) Research Group. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol. 2003;121:99–107. doi: 10.1001/archopht.121.1.99. PubMed DOI
Baker ML, Allen P, Shortt J, Lewin SR, Spencer A. Immune recovery uveitis in an HIV-negative individual. Clin Experiment Ophthalmol. 2007;35:189–190. doi: 10.1111/j.1442-9071.2006.01439.x. PubMed DOI
Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. doi: 10.1186/1743-422X-5-47. PubMed DOI PMC
Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F. Cytomegalovirus Retinitis and Viral Resistance Study Group. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis. 2001;183:333–337. doi: 10.1086/317931. PubMed DOI
Hoang QV, Simon DM, Kumar GN, Oh F, Goldstein DA. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Graefes Arch Clin Exp Ophthalmol. 2010;248:737–740. doi: 10.1007/s00417-009-1283-3. PubMed DOI
Derzko-Dzulynsky LA, Berger AR, Berinstein NL. Cytomegalovirus retinitis and low-grade non-Hodgkin’s lymphoma: case report and review of the literature. Am J Hematol. 1998;57:228–232. doi: 10.1002/(SICI)1096-8652(199803)57:3<228::AID-AJH9>3.0.CO;2-X. PubMed DOI
Gooi P, Farmer J, Hurley B, Brodbaker E. Cytomegalovirus retinitis mimicking intraocular lymphoma. Clin Ophthalmol. 2008;2:969–971. PubMed PMC
Sjövall J, Bergdahl S, Movin G, Ogenstad S, Saarimäki M. Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother. 1989;33:1023–1031. doi: 10.1128/AAC.33.7.1023. PubMed DOI PMC